Biosimilar epoetin: a new chapter is opening
Del Vecchio, L.
Giornale Italiano di Nefrologia Organo Ufficiale Della Societa Italiana di Nefrologia 25(4): 385
2008
ISSN/ISBN: 0393-5590 PMID: 18663682 Document Number: 627759
Document emailed within 1 workday
Related Documents
Thanakitcharu, P.; Siriwiwatanakul, N. 2007: Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia Journal of the Medical Association of Thailand 90(12): 2574-2586Veys, N.; Dhondt, A.; Lameire, N. 1998: Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta Clinical Nephrology 49(1): 41-44
Hirnle, L.; Zmijewski, J.; Kłósek, A. 2000: Meaning of opening form of internal cervical opening in prognosis of cervical insufficiency Ginekologia Polska 71(4): 279-283
Reinke, T. 2017: The Biosimilar Pipeline Seams Seem to be Bursting Managed Care 26(3): 24-25
Škvor, J. 2015: Experiences with biosimilar drugs in therapy Vnitrni Lekarstvi 61(3): 207-208
Kes, P.; Mesar, I.; Bašić-Jukić, N.; Rački, S. 2014: What doctors need to know about biosimilar medicinal products? Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 68(2): 201-205
Nau, J.-Y. 2006: Omnitrope, first "biosimilar" drug of the European Union Revue Medicale Suisse 2(64): 1206
Hornyák, L.; Nagy, Z.; Tálos, Z.; Endrei, D.ór.; Ágoston, I.án.; Csákvári, T.ím.; Boncz, I. 2014: Experiences with price competition of biosimilar drugs in Hungary Acta Pharmaceutica Hungarica 84(2): 83-87
Khabirov, F.A.; Babicheva, N.N.; Khaĭbullin, T.I.; Aver'ianova, L.A.; Granatov, E.V.; Akhmedova, G.M. 2012: Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(9 Part 2): 113-122
Van Vlijmen, B.; van Gool, L.; Repping-Wuts, H.; Ketels, T.; Kerstens, M.; Burger, D.; Hermus, A.; Smit, J. 2017: Successful switch from originator to biosimilar growth hormone: patients' experiences Nederlands Tijdschrift Voor Geneeskunde 161: D1415
Brodniewicz-Proba, T. 2008: The scope and requirements related to preclinical and clinical studies of a new medicinal product, including biotechnological and biosimilar products Acta Poloniae Pharmaceutica 65(6): 641-645
1989: Epoetin alfa: patient management Anna Journal 16(5): 348-350
Flaharty, K.K.; Grimm, A.M.; Vlasses, P.H. 1989: Epoetin: human recombinant erythropoietin Clinical Pharmacy 8(11): 769-782
Komar, O.; Rodriguez, W. 1995: Avian diversity at El Imposible National Park and San Marcelino Wildlife Refuge, El Salvador Chapter 5 preliminary evaluation of the habitat and the birds of San Diego and La Barra natural area, El Salvador Diversidad de avifauna en el Parque Nacional El Imposible y el Refugio de Vida Silvestre Complejo San Marcelino, El Salvador Chapter 5 evaluacion preliminar del habitat y las aves del Area natural San Diego y La Barra, El Salvador Wildlife Conservation Society Working Paper 30 November; 4: 69-76
Roger, S.D. 2007: Chronic kidney disease, anemia, and epoetin New England Journal of Medicine 356(9): 958; Author Reply 958-959
Mikhail, A.; Goldsmith, D. 2007: Chronic kidney disease, anemia, and epoetin New England Journal of Medicine 356(9): 956
Kharagjitsingh, A.V.; Dekker, F.W.; Vandenbroucke, J.P. 2004: Epoetin-induced pure red-cell aplasia Nederlands Tijdschrift Voor Geneeskunde 148(51): 2550-2553
Ashrani, A.A.; Rajkumar, S.Vincent. 2007: Chronic kidney disease, anemia, and epoetin New England Journal of Medicine 356(9): 957
Patel, T.V.; Robinson, K.; Singh, A.K. 2007: Is it time to reconsider subcutaneous administration of epoetin? Nephrology News and Issues 21(11): 57; 59 63-574 Passim
York, S.; Kinney, R.; Taber, T.E. 1991: Self-administration of epoetin beta by peritoneal dialysis patients Anna Journal 18(6): 549-552